Clinical trial · Interventional
Reflects the Intervention (AI Chatbot)
Empowering Breast Cancer Clients Through AI Chatbots: Transforming Knowledge and Attitudes for Enhanced Nursing Care
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to investigate the impact of an AI-powered chatbot intervention on improving knowledge, attitudes, and empowerment in breast cancer patients. The study focuses on female breast cancer patients, aged 18 years or older, who are receiving treatment at Kafr El-Sheikh University Hospital in Egypt. The main questions it aims to answer are: Can the AI chatbot intervention improve breast cancer knowledge compared to standard care? Can the AI chatbot intervention positively influence attitudes toward AI in healthcare? Does the AI chatbot intervention enhance patient empowerment in managing breast cancer? Researchers will compare: Intervention group (AI chatbot + standard care) to control group (standard care alone) to see if the AI chatbot intervention leads to greater improvements in knowledge, more positive attitudes towards AI, and higher perceived empowerment. Participants will: Engage with an AI-powered chatbot designed to provide personalized education on breast cancer, treatment options, and emotional support. Complete pre- and post-intervention assessments to measure changes in knowledge, attitudes toward AI, and empowerment. Receive standard care, including routine oncology consultations and nursing support, alongside the chatbot intervention (for the intervention group).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Early Stage Breast Cancer (Stage 1-3) | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| AI Chatbot for Breast Cancer Patient Education and Empowerment | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention Group (AI Chatbot + Standard Care)
- description
- Participants in this arm will receive standard oncology care in addition to interacting with an AI-powered chatbot. The chatbot will provide personalized educational content on breast cancer, treatment options, side effects, and offer emotional support. Participants will engage with the chatbot for 4 weeks, with assessments at baseline and post-interventi
- interventionNames
- Behavioral: AI Chatbot for Breast Cancer Patient Education and Empowerment
- type
- NO_INTERVENTION
- label
- Control Group (Standard Care Only)
- description
- Participants in this arm will receive standard oncology care only, including routine consultations with oncology specialists and nurses. They will not have access to the AI chatbot intervention.
Primary outcomes (1)
- measure
- Breast Cancer Knowledge Improvement
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Female participants diagnosed with breast cancer, regardless of cancer stage. Age 18 years or older. Ability to read and communicate in Arabic to interact with the AI chatbot. Willingness to participate in the study and to engage with the AI chatbot for the duration of the intervention. Ability to provide informed consent. Exclusion Criteria: Participants with cognitive impairments or serious mental health conditions that may hinder understanding or participation in the study. Patients currently receiving palliative care, as they may prioritize symptom management over educational interventions. Participants who are physically unable to engage with the study's digital tools or complete assessments (e.g., due to severe illness). Individuals who are unable to communicate in Arabic, as the AI chatbot intervention is designed in Arabic.
References
Publications (7)
- RESULTJanopaul-Naylor JR, Koo A, Qian DC, McCall NS, Liu Y, Patel SA. Physician Assessment of ChatGPT and Bing Answers to American Cancer Society's Questions to Ask About Your Cancer. Am J Clin Oncol. 2024 Jan 1;47(1):17-21. doi: 10.1097/COC.0000000000001050. Epub 2023 Oct 12. PMID 37823708
- RESULTSiglen E, Vetti HH, Lunde ABF, Hatlebrekke TA, Stromsvik N, Hamang A, Hovland ST, Rettberg JW, Steen VM, Bjorvatn C. Ask Rosa - The making of a digital genetic conversation tool, a chatbot, about hereditary breast and ovarian cancer. Patient Educ Couns. 2022 Jun;105(6):1488-1494. doi: 10.1016/j.pec.2021.09.027. Epub 2021 Oct 6. PMID 34649750
- RESULTAgrawal A. Fairness in AI-Driven Oncology: Investigating Racial and Gender Biases in Large Language Models. Cureus. 2024 Sep 16;16(9):e69541. doi: 10.7759/cureus.69541. eCollection 2024 Sep. PMID 39416584
- RESULTMa Y, Achiche S, Pomey MP, Paquette J, Adjtoutah N, Vicente S, Engler K; MARVIN chatbots Patient Expert Committee; Laymouna M, Lessard D, Lemire B, Asselah J, Therrien R, Osmanlliu E, Zawati MH, Joly Y, Lebouche B. Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study). JMIR Res Protoc. 2024 Feb 13;13:e54668. doi: 10.2196/54668. PMID 38349734
- RESULTChang YC, Wu CH, Lupo R, Botti S, Conte L, Vitone M, Massafra R, De Nunzio G, Vitale E. Generative Artificial Intelligence (AI) to Uncover Insights From Breast Cancer Patients' Perceptions to Mindfulness-Based Stress Reduction (MBSR) Interventions. Holist Nurs Pract. 2025 Sep-Oct 01;39(5):317-325. doi: 10.1097/HNP.0000000000000677. Epub 2025 Aug 13. PMID 39186509
- RESULTSato A, Haneda E, Hiroshima Y, Narimatsu H. Preliminary Screening for Hereditary Breast and Ovarian Cancer Using an AI Chatbot as a Genetic Counselor: Clinical Study. J Med Internet Res. 2024 Nov 27;26:e48914. doi: 10.2196/48914.